Anavex Life Sciences Corp (AVXL)

[sokol]

I added to my position today. Despite the move down the last few days, fundamentally nothing has changed. The multi-billion dollar potential for Anavex drugs is still there. I believe that the up-listing will mean a much larger shareholder base and more exposure for this broader base to consider Anavex’s prospective groundbreaking drug therapy. Alzheimer’s therapies alone will grab much attention, not to mention Parkinson’s disease, etc. Lastly, Clay Trader after the close today presented his chart, which he says is a “beautiful” over-all long term chart. Long term it looks like a beauty to me as well. Once again, I am glad I added to my position.